Abivax to Present Obefazimod Data at UEG Week 2026
Abivax announced it will present data on its drug Obefazimod at the United European Gastroenterology (UEG) Week 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Abivax to present obefazimod data at UEG Week 2026
Abivax said it will present data on obefazimod at United European Gastroenterology Week 2026.
Abivax names new Chief Medical Officer, Chief Technical Officer
Abivax has appointed Chris Rabbat as Chief Medical Officer and Tim Kelly as Chief Technical Officer. The company reported cash, cash equivalents and short-term investments of €402.4 million as of June 30, 2026, with cash runway into Q4 2029 after an early July public offering.